HIV/에이즈 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The HIV/AIDS Diagnostics Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.78 Billion (2025) growing at a CAGR of 10.44% during 2026-2034.

The Global HIV/AIDS Diagnostics market is expanding steadily due to increased awareness, early detection programs, and global health initiatives. HIV diagnostics play a crucial role in controlling the spread of infection by enabling early diagnosis and timely treatment. Governments and international organizations are investing heavily in screening campaigns and laboratory infrastructure to improve access to testing services.

Major growth drivers include the rising number of testing programs, availability of rapid diagnostic kits, and improvements in laboratory technologies. Point-of-care testing and self-testing kits have significantly increased accessibility, especially in developing regions. In addition, ongoing research for more accurate and faster diagnostic tools is enhancing detection rates and supporting better patient management strategies.

In the coming years, the market is expected to grow with continuous global efforts to eliminate HIV/AIDS as a public health threat. Technological advancements in molecular diagnostics and digital health integration will improve efficiency and monitoring. Africa and Asia-Pacific are expected to witness strong growth due to high testing demand, while developed regions focus on advanced and automated diagnostic systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits And Reagents
• Others

By Test Type

• Nucleic Acid Tests
• Rapid Tests (POC)
• ELISA
• Others

By End-user

• Private Diagnostics Laboratories
• Hospitals
• Research Institutes & Others
• Academic

COMPANIES PROFILED

• Hologic Inc, Alere, BioRad Laboratories, Abbott Laboratories, F HoffmannLa Roche Ltd, OraSure Technologies Inc, Siemens Healthineers, Chembio Diagnostic Systems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Nucleic Acid Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Tests (POC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Private Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Institutes & Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV/AIDS DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Hologic Inc
  • 9.2.2 Alere
  • 9.2.3 Bio-Rad Laboratories
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 OraSure Technologies Inc
  • 9.2.7 Siemens Healthineers
  • 9.2.8 Chembio Diagnostic Systems